We have located links that may give you full text access.
Procoagulant Substance and Mechanism of Myristica fragrans.
Journal of Medicinal Food 2016 November
The effect and mechanisms of Myristica fragrans on blood clotting were evaluated by evaluating blood coagulation time and the fibrinolytic system. The compounds 2 and 5 were isolated from the herbal extract and their activities were assessed for the first time. None of the tested compounds had fibrinolytic activity, but could inhibit the fibrinolytic activity of urokinase. Compound 2 showed the highest inhibitory activity (IC50 = 1.747 mg·mL(-1)) followed by compounds 4 (IC50 = 1.818 mg·mL(-1)) and 1 (IC50 = 2.407 mg·mL(-1)), which were higher than that of the compound in Danshen drug tablets (IC50 = 6.577 mg·mL(-1)) used in China. Moreover, compounds 1 and 2 showed strong α-glucosidase inhibitory activity in a dose-dependent manner with IC50 values 21.76 ± 0.59 and 21.31 ± 0.00 μg·mL(-1), respectively. These results demonstrated that the compounds are promising candidates as procoagulant and antidiabetic agents.
Full text links
Related Resources
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app